within Pharmacolibrary.Drugs.ATC.A;

model A10AD01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.02,
    adminDuration  = 600,
    adminMass      = 0.0001,
    adminCount     = 1,
    Vd             = 9.5e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00055,
    Tlag           = 720
  );

  annotation(Documentation(
    info ="<html><body><p>Human insulin is a polypeptide hormone used to regulate blood glucose levels in the treatment of diabetes mellitus (Type 1 and Type 2). It mimics the action of endogenous insulin and is approved for clinical use worldwide in both adult and pediatric populations to control hyperglycemia.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters based on published study in healthy male subjects following subcutaneous administration of regular human insulin.</p><h4>References</h4><ol><li>Erica Nishimura, Lone Pridal, Tine Glendorf, Bo Falk Hansen, František Hubálek, Thomas Kjeldsen, Niels Rode Kristensen, Anne Lützen, Karsten Lyby, Peter Madsen, Thomas Åskov Pedersen, Rasmus Ribel-Madsen, Carsten Enggaard Stidsen, Hanne Haahr,Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.,BMJ open diabetes research & care,2021<a href='https://pubmed.ncbi.nlm.nih.gov/34413118/'>https://pubmed.ncbi.nlm.nih.gov/34413118/</a></li><li>Helena W Rodbard, David Rodbard,Biosynthetic Human Insulin and Insulin Analogs.,American journal of therapeutics,2020<a href='https://pubmed.ncbi.nlm.nih.gov/31876563/'>https://pubmed.ncbi.nlm.nih.gov/31876563/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A10AD01;
